Ledger.Open graph →
SEC Form D · filed June 26, 2023

Infinity Bio, Inc

Offering
$4.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Benjamin Larman · Baltimore, MDDirectorMatthew Hellauer · Baltimore, MDDirectorCaroline Popper · Woburn, MAExec · DirectorBenjamin Larman · Baltimore, MDDirectorCaroline Popper · Seattle, WAExec · DirectorMatthew Hellauer · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗